Cost-effectiveness of using an extensively hydrolysed casein formula supplemented with Lactobacillus rhamnosus GG in managing igE-mediated cow's milk protein allergy in the UK.

CONCLUSION: First-line management of newly-diagnosed infants with IgE-mediated CMPA with eHCF plus LGG instead of eHCF alone improves outcome, releases healthcare resources for alternative use, reduces the NHS cost of patient management and thereby affords a cost-effective dietetic strategy to the NHS. PMID: 31025591 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research